Skip to content

Evaluation of a cognitive-behavioral and systemic-solution-oriented short-term intervention to cope with fear of progression in families with children with cancer entitled "Shared fear, brave together"

Evaluation of a cognitive-behavioral and systemic-solution-oriented short-term intervention to cope with fear of progression in families with children with cancer entitled "Shared fear, brave together"

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024106
Enrollment
24
Registered
2022-05-04
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fear of progression

Interventions

Group 1: Patients and a main caregiver with fear of progression receive the intervention with 8 therapeutic sessions and are questioned in a pre/post design using questionnaires on fear of progression

Sponsors

Selbstständige Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: Children aged 0 to 17 years with a diagnosis of cancer and/or a parent or primary caregiver (e.g. legal guardian where applicable). Patients in inpatient treatment at the pediatric oncology ward of the University Hospital Leipzig or in the aftercare phase at the association Elternhilfe für krebskranke Kinder Leipzig e.V. Children and parents with sufficient German language skills (at least language level B1 according to GER). Declaration of informed consent to study participation.

Exclusion criteria

Exclusion criteria: Patients in palliative care. Patients with cognitive or physical impairments that would limit participation in the intervention.

Design outcomes

Primary

MeasureTime frame
The primary outcome variables are fear of progression of children and parents, assessed using the short form of the fear of progression questionnaire for children with cancer (FoP-Q-SF/C) and the short form of the fear of progression questionnaire for parents of children with cancer (FoP-Q-SF/PR). The evaluation of the intervention (N=24 participants and/or one parent/main caregiver) is designed with a waiting control group and three measurement times: baseline (BL), post measurement after the intervention or after a waiting period (t1) and another measurement 4 months after completion of participation in the intervention (t2).

Secondary

MeasureTime frame
Secondary outcome variables for children are anxiety, depression, post-traumatic stress, quality of life, and emotion regulation strategies. Secondary outcome variables for parents are anxiety and depression, post-traumatic stress, and quality of life. The socio-demographic background of the child and the parents as well as medical information about the cancer are also collected.

Countries

Germany

Contacts

Public ContactJessy Herrmann

Elternhilfe für krebskranke Kinder Leipzig e.V.

herrmann@elternhilfe-leipzig.de017642712863

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jul 14, 2026